Samalin Investment Counsel, LLC Nkarta, Inc. Transaction History
Samalin Investment Counsel, LLC
- $234 Million
- Q1 2025
A detailed history of Samalin Investment Counsel, LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Samalin Investment Counsel, LLC holds 153,425 shares of NKTX stock, worth $254,685. This represents 0.12% of its overall portfolio holdings.
Number of Shares
153,425
Previous 84,575
81.41%
Holding current value
$254,685
Previous $210,000
34.29%
% of portfolio
0.12%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding NKTX
# of Institutions
118Shares Held
61MCall Options Held
13.7KPut Options Held
10.3K-
Ra Capital Management, L.P. Boston, MA10.8MShares$17.9 Million0.41% of portfolio
-
Tang Capital Management LLC San Diego, CA7.06MShares$11.7 Million0.84% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$6.74 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$6.25 Million3.2% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$5.92 Million0.62% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $80.8M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...